1 | act | 3,902 |
2 | acts | 1,729 |
3 | let | 243 |
4 | behave | 181 |
5 | behaved | 122 |
6 | functioned | 108 |
7 | 'treatment | 67 |
8 | behaves | 66 |
9 | tho | 21 |
10 | 'care | 18 |
11 | 'd | 18 |
12 | lets | 18 |
13 | monoracial | 14 |
14 | pfrd | 11 |
15 | self-labeling | 10 |
16 | epi/doc | 7 |
17 | alan | 6 |
18 | haematoxylon | 6 |
19 | p2a2 | 6 |
20 | pfbs | 6 |
21 | 3-hana | 5 |
22 | 36245-phf | 5 |
23 | cvp-bias | 5 |
24 | dhcb | 5 |
25 | emgb | 5 |
26 | px20606 | 5 |
27 | rcan1s | 5 |
28 | rs2108622 | 5 |
29 | wid | 5 |
30 | 17pa | 4 |
31 | 7a-f | 4 |
32 | arid3a | 4 |
33 | atg38 | 4 |
34 | brs-3-ap | 4 |
35 | ivdex | 4 |
36 | mfai | 4 |
37 | self-ranked | 4 |
38 | tupaia | 4 |
39 | 'apps | 3 |
40 | 1.5±1.0 | 3 |
41 | 2-hydrazinobenzothiazole | 3 |
42 | 2-methyl-4-chlorophenol | 3 |
43 | 3a-j | 3 |
44 | bmhsp20.4 | 3 |
45 | cd00509 | 3 |
46 | ddl-1/2 | 3 |
47 | denatonium | 3 |
48 | e-cylinders | 3 |
49 | e-screening | 3 |
50 | evaporates | 3 |
51 | hcscs | 3 |
52 | ica-v | 3 |
53 | lihsp83 | 3 |
54 | petrochemicals | 3 |
55 | ramazzini | 3 |
56 | sag-m | 3 |
57 | scep | 3 |
58 | stock-out | 3 |
59 | udp-n-acetylglucosamine | 3 |
60 | 'mask | 2 |
61 | 2g/daily | 2 |
62 | 3,4-dbp | 2 |
63 | 330nm | 2 |
64 | 5mecyt | 2 |
65 | 95/5 | 2 |
66 | ap-swath | 2 |
67 | asaxs | 2 |
68 | beta1-aabs | 2 |
69 | bgmv | 2 |
70 | c-point | 2 |
71 | cis-geraniol | 2 |
72 | climi | 2 |
73 | co-eluted | 2 |
74 | cps/gtcs | 2 |
75 | csaids | 2 |
76 | ctbp1 | 2 |
77 | diborane | 2 |
78 | dvl | 2 |
79 | encyst | 2 |
80 | feedback-suppressed | 2 |
81 | girault | 2 |
82 | hdics | 2 |
83 | his125 | 2 |
84 | hsp65-x14-βhcgctp37 | 2 |
85 | hssgc | 2 |
86 | ikkɛ | 2 |
87 | ilvlci | 2 |
88 | mir-30 | 2 |
89 | mune | 2 |
90 | nct00770003 | 2 |
91 | neofunctionalization | 2 |
92 | non-pretreatment | 2 |
93 | npevs | 2 |
94 | ohra | 2 |
95 | oxa-10 | 2 |
96 | pfds | 2 |
97 | phlame | 2 |
98 | photobioreactors | 2 |
99 | ppres | 2 |
100 | redcord | 2 |
101 | rifles | 2 |
102 | rs3796863 | 2 |
103 | sio2-oct-t400 | 2 |
104 | thte | 2 |
105 | ubiquitylates | 2 |
106 | vb_ecos_acg-m12 | 2 |
107 | ~15° | 2 |
108 | β-1,6-glucans | 2 |
109 | ∆acecs | 2 |
110 | 'attached | 1 |
111 | 'boomerang | 1 |
112 | 'duplicate | 1 |
113 | 'memorize | 1 |
114 | 'overwrite | 1 |
115 | 'up-regulate | 1 |
116 | -antagonism | 1 |
117 | -could | 1 |
118 | 1'-4 | 1 |
119 | 10,253 | 1 |
120 | 10dl | 1 |
121 | 9.54±0.42 | 1 |
122 | alemtuzumab-56 | 1 |
123 | alpha-2,3 | 1 |
124 | amyand | 1 |
125 | antipyretics-analgesics | 1 |
126 | assessed:1 | 1 |
127 | awareness/education | 1 |
128 | bavail/kd | 1 |
129 | bmhsp21.4 | 1 |
130 | c7-oh | 1 |
131 | carboplatin-methotrexate-vinblastine | 1 |
132 | chlamydia-unipath | 1 |
133 | cl-4b | 1 |
134 | cogenerator | 1 |
135 | compliance-defined | 1 |
136 | conditions/stimulant | 1 |
137 | cost/risk | 1 |
138 | dominant-additive | 1 |
139 | don-3-glc-lactone | 1 |
140 | ethane-1,2-diamine | 1 |
141 | examination-two | 1 |
142 | fl-induced | 1 |
143 | fl-only | 1 |
144 | flamers | 1 |
145 | forbaicalin | 1 |
146 | gannavaram | 1 |
147 | green-synthesized | 1 |
148 | hc3+ | 1 |
149 | hdac1/hdac2 | 1 |
150 | hipscs | 1 |
151 | inferior-is | 1 |
152 | iterate | 1 |
153 | l-boronophenylalanine | 1 |
154 | masculinist | 1 |
155 | medicine-homeopathy-teaches | 1 |
156 | mir218-1/-2 | 1 |
157 | multi-morbidities | 1 |
158 | multifractions | 1 |
159 | n-vinylimidazole | 1 |
160 | non-moabs | 1 |
161 | one-vessel-disease | 1 |
162 | oxabicycle | 1 |
163 | p1-p6 | 1 |
164 | periopathogenic | 1 |
165 | postconditionig | 1 |
166 | pre-mutagenic | 1 |
167 | programwise | 1 |
168 | quire | 1 |
169 | rvg29 | 1 |
170 | score=11 | 1 |
171 | skin-characteristics | 1 |
172 | snrv | 1 |
173 | survey-2012 | 1 |
174 | tacitly | 1 |
175 | tools-such | 1 |
176 | vs.te | 1 |
177 | β-hydroxyketones | 1 |
178 | ω9c | 1 |
1 | 'apps | 3 |
2 | 'attached | 1 |
3 | 'boomerang | 1 |
4 | 'care | 18 |
5 | 'd | 18 |
6 | 'duplicate | 1 |
7 | 'mask | 2 |
8 | 'memorize | 1 |
9 | 'overwrite | 1 |
10 | 'treatment | 67 |
11 | 'up-regulate | 1 |
12 | -antagonism | 1 |
13 | -could | 1 |
14 | 1'-4 | 1 |
15 | 1.5±1.0 | 3 |
16 | 10,253 | 1 |
17 | 10dl | 1 |
18 | 17pa | 4 |
19 | 2-hydrazinobenzothiazole | 3 |
20 | 2-methyl-4-chlorophenol | 3 |
21 | 2g/daily | 2 |
22 | 3,4-dbp | 2 |
23 | 3-hana | 5 |
24 | 330nm | 2 |
25 | 36245-phf | 5 |
26 | 3a-j | 3 |
27 | 5mecyt | 2 |
28 | 7a-f | 4 |
29 | 9.54±0.42 | 1 |
30 | 95/5 | 2 |
31 | act | 3,902 |
32 | acts | 1,729 |
33 | alan | 6 |
34 | alemtuzumab-56 | 1 |
35 | alpha-2,3 | 1 |
36 | amyand | 1 |
37 | antipyretics-analgesics | 1 |
38 | ap-swath | 2 |
39 | arid3a | 4 |
40 | asaxs | 2 |
41 | assessed:1 | 1 |
42 | atg38 | 4 |
43 | awareness/education | 1 |
44 | bavail/kd | 1 |
45 | behave | 181 |
46 | behaved | 122 |
47 | behaves | 66 |
48 | beta1-aabs | 2 |
49 | bgmv | 2 |
50 | bmhsp20.4 | 3 |
51 | bmhsp21.4 | 1 |
52 | brs-3-ap | 4 |
53 | c-point | 2 |
54 | c7-oh | 1 |
55 | carboplatin-methotrexate-vinblastine | 1 |
56 | cd00509 | 3 |
57 | chlamydia-unipath | 1 |
58 | cis-geraniol | 2 |
59 | cl-4b | 1 |
60 | climi | 2 |
61 | co-eluted | 2 |
62 | cogenerator | 1 |
63 | compliance-defined | 1 |
64 | conditions/stimulant | 1 |
65 | cost/risk | 1 |
66 | cps/gtcs | 2 |
67 | csaids | 2 |
68 | ctbp1 | 2 |
69 | cvp-bias | 5 |
70 | ddl-1/2 | 3 |
71 | denatonium | 3 |
72 | dhcb | 5 |
73 | diborane | 2 |
74 | dominant-additive | 1 |
75 | don-3-glc-lactone | 1 |
76 | dvl | 2 |
77 | e-cylinders | 3 |
78 | e-screening | 3 |
79 | emgb | 5 |
80 | encyst | 2 |
81 | epi/doc | 7 |
82 | ethane-1,2-diamine | 1 |
83 | evaporates | 3 |
84 | examination-two | 1 |
85 | feedback-suppressed | 2 |
86 | fl-induced | 1 |
87 | fl-only | 1 |
88 | flamers | 1 |
89 | forbaicalin | 1 |
90 | functioned | 108 |
91 | gannavaram | 1 |
92 | girault | 2 |
93 | green-synthesized | 1 |
94 | haematoxylon | 6 |
95 | hc3+ | 1 |
96 | hcscs | 3 |
97 | hdac1/hdac2 | 1 |
98 | hdics | 2 |
99 | hipscs | 1 |
100 | his125 | 2 |
101 | hsp65-x14-βhcgctp37 | 2 |
102 | hssgc | 2 |
103 | ica-v | 3 |
104 | ikkɛ | 2 |
105 | ilvlci | 2 |
106 | inferior-is | 1 |
107 | iterate | 1 |
108 | ivdex | 4 |
109 | l-boronophenylalanine | 1 |
110 | let | 243 |
111 | lets | 18 |
112 | lihsp83 | 3 |
113 | masculinist | 1 |
114 | medicine-homeopathy-teaches | 1 |
115 | mfai | 4 |
116 | mir-30 | 2 |
117 | mir218-1/-2 | 1 |
118 | monoracial | 14 |
119 | multi-morbidities | 1 |
120 | multifractions | 1 |
121 | mune | 2 |
122 | n-vinylimidazole | 1 |
123 | nct00770003 | 2 |
124 | neofunctionalization | 2 |
125 | non-moabs | 1 |
126 | non-pretreatment | 2 |
127 | npevs | 2 |
128 | ohra | 2 |
129 | one-vessel-disease | 1 |
130 | oxa-10 | 2 |
131 | oxabicycle | 1 |
132 | p1-p6 | 1 |
133 | p2a2 | 6 |
134 | periopathogenic | 1 |
135 | petrochemicals | 3 |
136 | pfbs | 6 |
137 | pfds | 2 |
138 | pfrd | 11 |
139 | phlame | 2 |
140 | photobioreactors | 2 |
141 | postconditionig | 1 |
142 | ppres | 2 |
143 | pre-mutagenic | 1 |
144 | programwise | 1 |
145 | px20606 | 5 |
146 | quire | 1 |
147 | ramazzini | 3 |
148 | rcan1s | 5 |
149 | redcord | 2 |
150 | rifles | 2 |
151 | rs2108622 | 5 |
152 | rs3796863 | 2 |
153 | rvg29 | 1 |
154 | sag-m | 3 |
155 | scep | 3 |
156 | score=11 | 1 |
157 | self-labeling | 10 |
158 | self-ranked | 4 |
159 | sio2-oct-t400 | 2 |
160 | skin-characteristics | 1 |
161 | snrv | 1 |
162 | stock-out | 3 |
163 | survey-2012 | 1 |
164 | tacitly | 1 |
165 | tho | 21 |
166 | thte | 2 |
167 | tools-such | 1 |
168 | tupaia | 4 |
169 | ubiquitylates | 2 |
170 | udp-n-acetylglucosamine | 3 |
171 | vb_ecos_acg-m12 | 2 |
172 | vs.te | 1 |
173 | wid | 5 |
174 | ~15° | 2 |
175 | β-1,6-glucans | 2 |
176 | β-hydroxyketones | 1 |
177 | ω9c | 1 |
178 | ∆acecs | 2 |
1 | hc3+ | 1 |
2 | 1.5±1.0 | 3 |
3 | sio2-oct-t400 | 2 |
4 | oxa-10 | 2 |
5 | mir-30 | 2 |
6 | score=11 | 1 |
7 | assessed:1 | 1 |
8 | ctbp1 | 2 |
9 | mir218-1/-2 | 1 |
10 | ddl-1/2 | 3 |
11 | survey-2012 | 1 |
12 | vb_ecos_acg-m12 | 2 |
13 | rs2108622 | 5 |
14 | 9.54±0.42 | 1 |
15 | p2a2 | 6 |
16 | hdac1/hdac2 | 1 |
17 | alpha-2,3 | 1 |
18 | nct00770003 | 2 |
19 | 10,253 | 1 |
20 | rs3796863 | 2 |
21 | lihsp83 | 3 |
22 | 1'-4 | 1 |
23 | bmhsp20.4 | 3 |
24 | bmhsp21.4 | 1 |
25 | 95/5 | 2 |
26 | his125 | 2 |
27 | px20606 | 5 |
28 | alemtuzumab-56 | 1 |
29 | p1-p6 | 1 |
30 | hsp65-x14-βhcgctp37 | 2 |
31 | atg38 | 4 |
32 | cd00509 | 3 |
33 | rvg29 | 1 |
34 | arid3a | 4 |
35 | tupaia | 4 |
36 | 3-hana | 5 |
37 | 17pa | 4 |
38 | ohra | 2 |
39 | cl-4b | 1 |
40 | dhcb | 5 |
41 | emgb | 5 |
42 | ω9c | 1 |
43 | hssgc | 2 |
44 | pre-mutagenic | 1 |
45 | periopathogenic | 1 |
46 | epi/doc | 7 |
47 | 'd | 18 |
48 | fl-induced | 1 |
49 | 'attached | 1 |
50 | self-ranked | 4 |
51 | compliance-defined | 1 |
52 | functioned | 108 |
53 | feedback-suppressed | 2 |
54 | co-eluted | 2 |
55 | behaved | 122 |
56 | green-synthesized | 1 |
57 | wid | 5 |
58 | bavail/kd | 1 |
59 | -could | 1 |
60 | amyand | 1 |
61 | pfrd | 11 |
62 | redcord | 2 |
63 | oxabicycle | 1 |
64 | n-vinylimidazole | 1 |
65 | 2-hydrazinobenzothiazole | 3 |
66 | phlame | 2 |
67 | diborane | 2 |
68 | ethane-1,2-diamine | 1 |
69 | udp-n-acetylglucosamine | 3 |
70 | l-boronophenylalanine | 1 |
71 | carboplatin-methotrexate-vinblastine | 1 |
72 | don-3-glc-lactone | 1 |
73 | mune | 2 |
74 | 'care | 18 |
75 | quire | 1 |
76 | one-vessel-disease | 1 |
77 | programwise | 1 |
78 | vs.te | 1 |
79 | 'duplicate | 1 |
80 | 'up-regulate | 1 |
81 | iterate | 1 |
82 | thte | 2 |
83 | 'overwrite | 1 |
84 | behave | 181 |
85 | dominant-additive | 1 |
86 | 'memorize | 1 |
87 | 7a-f | 4 |
88 | 36245-phf | 5 |
89 | postconditionig | 1 |
90 | 'boomerang | 1 |
91 | self-labeling | 10 |
92 | e-screening | 3 |
93 | tools-such | 1 |
94 | c7-oh | 1 |
95 | chlamydia-unipath | 1 |
96 | ap-swath | 2 |
97 | mfai | 4 |
98 | ilvlci | 2 |
99 | climi | 2 |
100 | ramazzini | 3 |
101 | 3a-j | 3 |
102 | 'mask | 2 |
103 | cost/risk | 1 |
104 | monoracial | 14 |
105 | 10dl | 1 |
106 | cis-geraniol | 2 |
107 | 2-methyl-4-chlorophenol | 3 |
108 | dvl | 2 |
109 | sag-m | 3 |
110 | gannavaram | 1 |
111 | 330nm | 2 |
112 | -antagonism | 1 |
113 | denatonium | 3 |
114 | alan | 6 |
115 | forbaicalin | 1 |
116 | awareness/education | 1 |
117 | neofunctionalization | 2 |
118 | haematoxylon | 6 |
119 | tho | 21 |
120 | examination-two | 1 |
121 | brs-3-ap | 4 |
122 | 3,4-dbp | 2 |
123 | scep | 3 |
124 | cogenerator | 1 |
125 | rcan1s | 5 |
126 | cvp-bias | 5 |
127 | beta1-aabs | 2 |
128 | non-moabs | 1 |
129 | pfbs | 6 |
130 | ∆acecs | 2 |
131 | hdics | 2 |
132 | antipyretics-analgesics | 1 |
133 | skin-characteristics | 1 |
134 | hcscs | 3 |
135 | hipscs | 1 |
136 | cps/gtcs | 2 |
137 | pfds | 2 |
138 | csaids | 2 |
139 | medicine-homeopathy-teaches | 1 |
140 | multi-morbidities | 1 |
141 | rifles | 2 |
142 | β-hydroxyketones | 1 |
143 | ppres | 2 |
144 | ubiquitylates | 2 |
145 | evaporates | 3 |
146 | behaves | 66 |
147 | inferior-is | 1 |
148 | petrochemicals | 3 |
149 | β-1,6-glucans | 2 |
150 | multifractions | 1 |
151 | 'apps | 3 |
152 | e-cylinders | 3 |
153 | flamers | 1 |
154 | photobioreactors | 2 |
155 | acts | 1,729 |
156 | lets | 18 |
157 | npevs | 2 |
158 | asaxs | 2 |
159 | act | 3,902 |
160 | let | 243 |
161 | girault | 2 |
162 | conditions/stimulant | 1 |
163 | 'treatment | 67 |
164 | non-pretreatment | 2 |
165 | c-point | 2 |
166 | masculinist | 1 |
167 | encyst | 2 |
168 | stock-out | 3 |
169 | 5mecyt | 2 |
170 | ica-v | 3 |
171 | bgmv | 2 |
172 | snrv | 1 |
173 | ivdex | 4 |
174 | 2g/daily | 2 |
175 | fl-only | 1 |
176 | tacitly | 1 |
177 | ikkɛ | 2 |
178 | ~15° | 2 |